Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Heart Function Through Blood Test Analysis of NT-proBNP During Treatment With HER2-Targeted Antibodies in HER2-Positive Breast Cancer - A Swedish Multicenter Study

NCT06340516 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT06340516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06340516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Heart Function Through Blood Test Analysis of NT-proBNP During Treatment With HER2-Targeted Antibodies in HER2-Positive Breast Cancer - A Swedish Multicenter Study
Lead sponsor
Vastra Gotaland Region
Phase
Not applicable
Overall status
Recruiting
Start date
March 14, 2024
Completion date
March 14, 2029
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiotoxicity, treatment side effects